Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9630932
APP PUB NO 20160200693A1
SERIAL NO

14784708

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitor compounds of formula (I), which may be therapeutically useful as DHODH inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AURIGENE ONCOLOGY LIMITED39/40 (P) KIADB INDUSTRIAL AREA ELECTRONICS CITY PHASE II BANGALORE KARNATAKA BANGALORE 560100 560100

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hosahalli, Subramanya Bangalore, IN 25 62
Kunnam, Satish Reddy Warangal, IN 4 16
Thunuguntla, Siva Sanjeeva Rao Hyderabad, IN 7 20

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 25, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00